Biofocus swings to profit in 2008
BioFocus DPI, the service division of Belgian drug discovery firm Galapagos, made a profit of €3.4m on revenues a little over €56m in 2008, reversing a loss of about the same magnitude in 2007.
Archives for March 11, 2009
UCB taps Proteros for crystallography services
Belgian biopharmaceutical company UCB has contracted Proteros Biostructures of Germany to provide support in the structure-based discovery of small-molecule drugs.
Genzyme accused of cGMP deficiencies by FDA
The FDA has found “significant objectionable conditions” at the Genzyme manufacturing facility that makes Lumizyme, creating another issue in the product’s approval process.
Re-importation bill would punish big pharma’s actions; Dorgan
Following the proposal of his bill re-importation bill Senator Byron Dorgan has accused some of big pharma of taking actions that would be illegal under the Act and outlined the punishments they could face.
Obama overturns stem cell research funding ban
The US green light for federally funded embryonic stem cell research is being hailed as a victory by the US drug industry, which predicts it will open the flood gates for novel medications and help revitalise the sector.
Richmond launches new data management offering
UK CRO Richmond Pharmacology has unveiled a new data management offering for the drug industry that it claims will help trial sponsors cut costs, save time and help guarantee data integrity.